Actual Medicinal Product (AMP) Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in an airtight container. Mixed results from stability studies (Studies show chemical stability in airtight containers up to 6 weeks but may discolour and crumble)
Provenance: This recommendation is based on the products Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd) and Clozapine 25mg tablets (Viatris).
Generic: Clozapine
Formulation: Clozapine 25mg tablets